Abstract:AbstractDeregulated activation of the latent oncogenic transcription factor STAT3 in many human epithelial malignancies, including gastric cancer, has invariably been associated with its canonical tyrosine phosphorylation and enhanced transcriptional activity. By contrast, serine phosphorylation (pS) of STAT3 can augment its nuclear transcriptional activity and promote essential mitochondrial functions, yet the role of pS–STAT3 among epithelial cancers is ill-defined. Here, we reveal that genetic ablation of pS–STAT3 in the gp130F/F spontaneous gastric cancer mouse model and human gastric cancer cell line xenografts abrogated tumor growth that coincided with reduced proliferative potential of the tumor epithelium. Microarray gene expression profiling demonstrated that the suppressed gastric tumorigenesis in pS–STAT3-deficient gp130F/F mice associated with reduced transcriptional activity of STAT3-regulated gene networks implicated in cell proliferation and migration, inflammation, and angiogenesis, but not mitochondrial function or metabolism. Notably, the protumorigenic activity of pS–STAT3 aligned with its capacity to primarily augment RNA polymerase II–mediated transcriptional elongation, but not initiation, of STAT3 target genes. Furthermore, by using a combinatorial in vitro and in vivo proteomics approach based on the rapid immunoprecipitation mass spectrometry of endogenous protein (RIME) assay, we identified RuvB-like AAA ATPase 1 (RUVBL1/Pontin) and enhancer of rudimentary homolog (ERH) as interacting partners of pS–STAT3 that are pivotal for its transcriptional activity on STAT3 target genes. Collectively, these findings uncover a hitherto unknown transcriptional role and obligate requirement for pS–STAT3 in gastric cancer that could be extrapolated to other STAT3-driven cancers.Significance:These findings reveal a new transcriptional role and mandatory requirement for constitutive STAT3 serine phosphorylation in gastric cancer.

STAT3 potentiates RNA polymerase I-directed transcription and tumor growth by activating RPA34 expression

STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis

Pan-cancer Analysis of STAT3 Indicates Its Potential Prognostic Value and Correlation with Immune Cell Infiltration in Prostate Cancer

CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner

STAT3 and Individualized Treatment of Tumors

Transcription factor AP-2α activates RNA polymerase III–directed transcription and tumor cell proliferation by controlling expression of c-MYC and p53

The Pivotal Role of STAT3 in Tumor Occurrence and Progress

STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors

Rna Interference-Mediated Signal Transducers And Activators Of Transcription 3 Gene Silencing Inhibits Invasion And Metastasis Of Human Pancreatic Cancer Cells

Transcription Factor Stat3 As An Oncogene

Multiple regulation pathways and pivotal biological functions of STAT3 in cancer

Roles Of Stat3 In Regulation Of Emt-Mediated Phenotypic Plasticity And Its Effects On Circulating Tumor Cells And Tumor Invasion And Metastases

The regulatory relationship between transcription factor STAT3 and noncoding RNA

Serine-Phosphorylated STAT3 Promotes Tumorigenesis Via Modulation of RNA Polymerase Transcriptional Activity

Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression

TMET-03. ONCOGENIC STAT3 PROMOTES TUMOR GROWTH VIA STIMULATION THE SCAP- AND SREBP-1-REGULATED LIPOGENIC PATHWAY

A Requirement Of Stat3 Dna Binding Precludes Th-1 Immunostimulatory Gene Expression By Nf-Kappa B In Tumors

Stat3 Inhibits PTPN13 Expression in Squamous Cell Lung Carcinoma Through Recruitment of HDAC5

Stat3-regulated Genes and Advances on Tumor Researches

STAT3 Contributes to Radioresistance in Cancer

Effect of Signal Transducer and Activator of Transcription 3 in Neoplasms Invasion and Metastasis